Literature DB >> 25903693

Papillary thyroid carcinoma and multiple endocrine neoplasia type 2.

B Febrero1, J M Rodríguez2, A Ríos2, P Portillo3, P Parrilla2.   

Abstract

INTRODUCTION: Papillary thyroid carcinoma (PTC) is exceptional in MEN 2.
RESULTS: The analysis in 135 patients revealed two PTC, without C-cell pathology; both being positive for V804M mutation (RET proto-oncogene).
CONCLUSIONS: Few data are available about PTC in MEN 2, and without C-cell pathology is even less common. More studies are needed to correlate genetics and histology, and even for assessing PTC as only manifestation of MEN 2.

Entities:  

Keywords:  Medullary carcinoma; Multiple endocrine neoplasia type 2; Papillary carcinoma; RET mutation; Thyroid carcinoma

Mesh:

Substances:

Year:  2015        PMID: 25903693     DOI: 10.1007/s40618-015-0290-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.

Authors:  Christopher Griffith; Shengle Zhang; Sanjay Mukhopadhyay
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

2.  Simultaneous medullary and papillary thyroid cancer: a novel entity?

Authors:  Andreas Machens; Henning Dralle
Journal:  Ann Surg Oncol       Date:  2011-05-28       Impact factor: 5.344

Review 3.  Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature.

Authors:  S Rossi; L Fugazzola; L De Pasquale; P Braidotti; V Cirello; P Beck-Peccoz; S Bosari; A Bastagli
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

4.  One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?

Authors:  Alexander L Shifrin; Cristina Xenachis; Angela Fay; Theodore J Matulewicz; Yen-Hong Kuo; Jerome J Vernick
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

5.  The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.

Authors:  Rosa Marina Melillo; Anna Maria Cirafici; Valentina De Falco; Marie Bellantoni; Gennaro Chiappetta; Alfredo Fusco; Francesca Carlomagno; Antonella Picascia; Donatella Tramontano; Giovanni Tallini; Massimo Santoro
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

6.  Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?

Authors:  J K Rone; A G Lane; M D Grinkemeyer
Journal:  Thyroid       Date:  1998-09       Impact factor: 6.568

7.  Simultaneous occurrence of papillary intrafollicular and microcarcinomas with bilateral medullary microcarcinoma of the thyroid in a patient with multiple endocrine neoplasia type 2A: report of a case.

Authors:  Mustafa Kösem; Cetin Kotan; Ekrem Algün; Cevat Topal
Journal:  Surg Today       Date:  2002       Impact factor: 2.549

Review 8.  Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.

Authors:  S Oishi; M Sasaki; T Sato; M Isogai
Journal:  Jpn J Clin Oncol       Date:  1995-08       Impact factor: 3.019

9.  Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.

Authors:  G Papi; S Corrado; M G Pomponi; C Carapezzi; A Cesinaro; V A LiVolsi
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.

Authors:  R A Decker
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

View more
  3 in total

1.  Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

Authors:  R Ciampi; C Romei; L Pieruzzi; A Tacito; E Molinaro; L Agate; V Bottici; F Casella; C Ugolini; G Materazzi; F Basolo; R Elisei
Journal:  J Endocrinol Invest       Date:  2016-08-17       Impact factor: 4.256

2.  Medullary Thyroid Carcinoma and Associated Endocrinopathies in Slovenia from 1995 to 2021.

Authors:  Sara Milicevic; Mateja Krajc; Ana Blatnik; Barbara Peric
Journal:  Life (Basel)       Date:  2022-07-21

3.  Occurrence of paratesticular ganglioneuroma 18 years after concurrent adrenal ganglioneuroma and papillary thyroid carcinoma - a case report.

Authors:  Chu-Wen Fang; Jyh-Seng Wang; Tony T Wu; Jen-Tai Lin
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.